Back

RESEARCH PLATFORM 3

R.P 3.4 Detection of Macular Degeneration and Myopia-Induced Retinal Damage Using Structured Light Technology

Principle Investigators

PolyU

Prof. Ka-man Rachel CHUN

UWaterloo

Prof. Benjamin THOMPSON

Overview

Early detection of retinal diseases can significantly improve disease management and treatment outcomes. This project aims to develop novel, objective diagnostic tools for early detection of age-related macular degeneration and myopia-induced retinal damage using structured light technology. The study is built around two complementary approaches. The first focuses on objective macular polarity imaging, analysing how structured light interacts with retinal nerve fibres to generate polarization profiles that reveal early retinal degeneration without relying on subjective patient responses. The second adapts structured light vision testing to detect retinal damage associated with pathological myopia by identifying localized distortions caused by excessive eye elongation.

Learn more about R.P 3.3 Learn more about R.P 3.5

R.P 1.1 Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

R.P 1.2 Anti-Myopia Electronic Displays: Making Screens Eye-Safe for Children

R.P 1.3 Advanced Technologies for Prediction of Myopia Progression

R.P 1.4 Targeting Higher-Level Brain Functions for Amblyopia Rehabilitation

R.P 1.5 Novel Neuromodulation Approaches for Vision Enhancement in Adults

R.P 2.1 Clinical Translation of a Novel Anti-Microbial Therapy for Eye Infections

R.P 2.2 An Organoid Platform and Cell-Based Platform for Ocular Therapeutic Development

R.P 2.3 Developing Next-Generation Therapeutic Agents for Glaucoma

R.P 2.4 Novel Gene Delivery Platforms for the Treatment of Ocular Disease

R.P 2.5 Integrated Dry Eye Diagnosis and Precision Therapies

R.P 2.6 Development of Ocular Inserts and Aptamer-Based Delivery Vehicles for Sustained Release of Ocular Therapeutics and TCM Products

R.P 3.1 Eye Disease Diagnosis and Treatment Enabled by Novel Retinal Instrumentation

R.P 3.2 Non-Invasive Tear-Based Diagnostic System

R.P 3.3 Development of New-Generation Contact Lenses Using Novel Materials and Additive Manufacturing

R.P 3.5 Extended Reality Visual Intelligence System (XRVIS) for Tele-Visual Assessment and Safety Enhancement for People with Visual Impairment

ENQUIRY